selected publications
-
academic article
- SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 72:2132-2140. 2021